IMDX — Insight Molecular Diagnostics Share News
0.000.00%
Last trade - 00:00- $92.61m
- $75.62m
- $4.06m
Brief: Oncocyte CEO Ronnie Andrews To Step down
U.S. RESEARCH ROUNDUP-Abbvie, Eli Lilly, Vroom
U.S. RESEARCH ROUNDUP-Coherent, Huntington Ingalls Industries, Spirit Aerosystems Holdings
U.S. STOCKS ON THE MOVE-UnitedHealth, Lifestyle, Exxon
U.S. STOCKS ON THE MOVE-LegalZoom, Snail, metal miners
U.S. STOCKS ON THE MOVE-Matterport, Grove Collaborative, Toast
Needham cuts OncoCyte PT on lower revenue estimates
OncoCyte Corp reports results for the quarter ended in September - Earnings Summary
Brief: Oncocyte Reports Third Quarter 2022 Financial Results
OncoCyte Corp expected to post a loss of 11 cents a share - Earnings Preview
Brief: Determaio™ Clinical Test To Be Used In Swog Cancer Research Network Biomarker Study For Breast Cancer
Brief: OncoCyte Announces Unanimous Recommendation From Advisory Panel For DetermaRx To CMS
Brief: Oncocyte Announces Five-Year VA Contract for DetermaRx
Brief: Oncocyte Announces Publication Of Validation Of Determaio In Predicting Immune Therapy Response In Metastatic Bladder Cancer
U.S. RESEARCH ROUNDUP- Analog Devices, Bath & Body Works, Synopsys
Brief: OncoCyte Received Letter From Nasdaq Regarding Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP- PLx pharma, Vroom, Walmart
OncoCyte Corp reports results for the quarter ended in June - Earnings Summary
Brief: Oncocyte Reports Second Quarter 2022 Financial Results